As a sort of addendum to this Monday’s post, I can’t believe I wrote the following testimonial four whole years ago. Ever more confirmation that the more things change, the more they stay the same:
Diab-entity Crisis
Sometime in the middle of last week, as I was gazing at my blog banner and mulling over my next post, I had a kind of out-of-body sensation for a moment: Am I still the same person who…
Dr. Stephen Ponder, who has Type 1 diabetes himself, has been a pediatric endocrinologist for 20 years. He is director of the Children’s Diabetes and Endocrine Center of South Texas at Driscoll Children’s Hospital. He’s also been working with a company called Diabetech on a diabetes monitoring device called GlucoMON for the past several years. Today, he has some big news to report.
But first, for those who are unfamiliar: GlucoMON is “a small, portable…
By far the most positive thing that has come out of getting this stupid chronic illness is meeting incredible people. Who knew there were so many wonderful kindred spirits out there, before I began connecting with others who struggle all day every day with carb counts and insulin dosing calcs and potentially dangerous blood sugar lows?
What I’m getting at is that I had the chance to meet another of these kindred souls in the…
I realize that we haven’t hit Christmas yet this year. And Hanukkah begins tonight at sundown — so maybe you haven’t yet experienced your Best or Worst of the Holidays with Diabetes for this year. But we’re asking anyway: share a story for a chance to win!
The DiabetesMine ‘Tis the Season! Survival Sweepstakes closes for submissions tonight at midnight Pacific. The idea was to gather past experiences in advance, to share with each other…
Many of you know that the FDA held public hearings on the pharma industry’s use of Social Media mid-last-month. There was much excitement going into this because to date, the FDA has pretty much dodged the subject, and left drugmakers in fear of retribution (see BusinessWeek‘s summary here).
Essentially, since there are no clear rules laid out for how pharma can and can’t advertise their wares online, and talk about them on blogs, social networks,…